Brief: Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
10/09/2025 13:43
Sept 10 (Reuters) - Actuate Therapeutics Inc ACTU.O: ACTUATE THERAPEUTICS ANNOUNCES PRICING OF $15.0 MILLION PUBLIC OFFERING OF COMMON STOCK ACTUATE THERAPEUTICS INC - PRICED 2,142,858 SHARES OF COMMON STOCK AT OFFERING PRICE OF $7 PER SHARE OF COMMON STOCK Source text: ID:nGNX45CmdT Further company coverage: ACTU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actuate Therapeutics
See all newsHealth Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing
Brief: Actuate Therapeutics Announces Positive Patient Outcomes From Phase 1 Trial
Brief: Actuate Therapeutics Inc - Enters At The Market Issuance Sales Agreement With B. Riley And Craig-Hallum - SEC Filing